Marshall Wace’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.5M | Buy |
1,969,711
+1,639,315
| +496% | +$35.4M | 0.05% | 308 |
|
|
2025
Q1 | $5.49M | Sell |
330,396
-663,197
| -67% | -$11M | 0.01% | 946 |
|
|
2024
Q4 | $18.2M | Sell |
993,593
-195,019
| -16% | -$3.58M | 0.02% | 534 |
|
|
2024
Q3 | $18.3M | Sell |
1,188,612
-1,585,741
| -57% | -$24.4M | 0.02% | 484 |
|
|
2024
Q2 | $45.1M | Buy |
2,774,353
+2,251,940
| +431% | +$36.6M | 0.06% | 268 |
|
|
2024
Q1 | $9.66M | Buy |
+522,413
| New | +$9.66M | 0.01% | 665 |
|
|
2023
Q4 | – | Sell |
-941,755
| Closed | -$19.6M | – | 1781 |
|
|
2023
Q3 | $19.6M | Buy |
941,755
+916,903
| +3,689% | +$19.1M | 0.04% | 409 |
|
|
2023
Q2 | $595K | Buy |
+24,852
| New | +$595K | ﹤0.01% | 1535 |
|
|
2022
Q2 | – | Sell |
-532,557
| Closed | -$12.9M | – | 2626 |
|
|
2022
Q1 | $12.9M | Buy |
+532,557
| New | +$12.9M | 0.02% | 655 |
|
|
2021
Q1 | – | Sell |
-848,679
| Closed | -$45.4M | – | 2055 |
|
|
2020
Q4 | $45.4M | Sell |
848,679
-285,133
| -25% | -$15.2M | 0.25% | 69 |
|
|
2020
Q3 | $46.8M | Buy |
1,133,812
+933,686
| +467% | +$38.5M | 0.3% | 59 |
|
|
2020
Q2 | $9.7M | Buy |
+200,126
| New | +$9.7M | 0.07% | 274 |
|
|
2016
Q2 | – | Sell |
-37,174
| Closed | -$1.04M | – | 953 |
|
|
2016
Q1 | $1.04M | Buy |
+37,174
| New | +$1.04M | 0.01% | 700 |
|
|
2015
Q2 | – | Sell |
-22,686
| Closed | -$739K | – | 879 |
|
|
2015
Q1 | $739K | Buy |
+22,686
| New | +$739K | 0.01% | 622 |
|